Concentrix is trading 5.3% down at $24.51, with the cause of the decline unclear.

  • A shareholder-rights firm publicized an investigation concerning earlier revenue outlook cuts and a $1.05 billion goodwill impairment; its report does not establish that it drove this session’s move.
  • Major U.S. indexes were up around 0.5% or more, so the decline does not appear to reflect the supplied broad-market trend.